S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONSE MAINTENANCE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN THE EUROPEAN STOP KINASE INHIBITORS (EURO-SKI) TRIAL

• Markus Pfirrmann,
• Francois-Xavier Mahon,
• Stéphanie Dulucq,
• Andreas Hochhaus,
• Panayiotis Panayiotidis,
• Antonio Almeida,
• Jiri Mayer,
• Henrik Hjorth-Hansen,
• Jeroen J. W. M. Janssen,
• Satu Mustjoki,
• Joaquín Martinez-Lopez,
• Hanne Vestergaard,
• Hans Ehrencrona,
• Veli Kairisto,
• Kateřina Machová Poláková,
• Franck Emmanuel Nicolini,
• Wolf-Karsten Hofmann,
• Joëlle Guilhot,
• Susanne Saussele,
• Johan Richter

Affiliations

Markus Pfirrmann

1 Ludwig-Maximilians-Universität München, Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, München, Germany

Francois-Xavier Mahon

2 Institut Bergonié, Hematology Department, Bordeaux, France

Stéphanie Dulucq

3 French group of CML (Fi-LMC), Lyon, France

Andreas Hochhaus

5 Universitätsklinikum Jena, Klinik für Innere Medizin II, Jena, Germany

Panayiotis Panayiotidis

6 National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Antonio Almeida

7 Universidade Católica Portuguesa de Lisboa, Centro de Investigação Interdisciplinar em Saúde, Lisbon, Portugal

Jiri Mayer

9 University Hospital Brno, Brno, Czech Republic

Henrik Hjorth-Hansen

10 Norwegian University of Science and Technology, Trondheim, Norway

Jeroen J. W. M. Janssen

12 Radboud University Medical Center, Nijmegen, The Netherlands

Satu Mustjoki

13 Helsinki University Central Hospital, Biomedicum, Helsinki, Finland

Joaquín Martinez-Lopez

14 Hospital Universitario 12 de Octubre, Hematology Department, Madrid, Spain

Hanne Vestergaard

15 Odense University Hospital, Department of Hematology, Odense, Denmark

Hans Ehrencrona

16 Skåne University Hospital, Department of Clinical Genetics, Lund, Sweden

Veli Kairisto

17 Turku University Central Hospital, Department of Clinical Chemistry, Turku, Finland

Kateřina Machová Poláková

18 Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Franck Emmanuel Nicolini

3 French group of CML (Fi-LMC), Lyon, France

Wolf-Karsten Hofmann

21 University Hospital Mannheim, Heidelberg University, Department of Hematology and Oncology, Mannheim, Germany

Joëlle Guilhot

3 French group of CML (Fi-LMC), Lyon, France

Susanne Saussele

21 University Hospital Mannheim, Heidelberg University, Department of Hematology and Oncology, Mannheim, Germany

Johan Richter

22 Skåne University Hospital, Department of Hematology, Oncology and Radiation Physics, Lund, Sweden